LEO 22811 - A Phase 1, Double-Blind, Placebo-controlled, Single and Multiple Oral Dose Study in Healthy Subjects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00833872
Recruitment Status : Completed
First Posted : February 2, 2009
Last Update Posted : March 3, 2016
Information provided by (Responsible Party):
LEO Pharma

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : October 2009
  Actual Study Completion Date : November 2009